Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

"71 out of 72 Wisconsin counties filed lawsuits against Purdue Pharma. Brad Schimel refused to join them," the ad states. That refers to litigation launched around 2017 in Wisconsin and nationwide ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay ...

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of lawsuits claiming they played a role in driving the opioid addiction ...

The company’s owners, the Sackler family, will pay $3 billion of the settlement out of their personal $13 billion fortune over the next seven years and give up control of Purdue Pharma.

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...

The U.S. Supreme Court is hearing many important cases this term, but perhaps none are as consequential — or controversial — as one involving Purdue Pharma. The long-maligned pharmaceutical ...

Purdue Pharma LP's patents covering its blockbuster painkiller OxyContin are invalid, according to Judge Sidney Stein of the US District Court for the Southern District of New York. The ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...